ArticleScientific reports2022

Ginsenoside Rh2 sensitizes the anti-cancer effects of sunitinib by inducing cell cycle arrest in renal cell carcinoma.

Hyun Ji Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.